Bicalutamide 50 Mg Film-Coated Tablets
Circulation No. 1
Bicalutamide 50mg-Pack Insert-Bordon-GBR+IRL
Windows (KP-VINODP) vinodp D:\FK-DATA\Europe\Bicalutamide\MRP\UK\Bicalutamide 50mg-Pack Insert-Bordon-GBR+IRL.indd
Package leaflet: Information for the user Bicalutamide 50 mg film-coated tablets
Bicalutamide
Read all of this leaflet carefully before you start taking this medicine because it contains important information for you.
- Keep this leaflet. You may need to read it again.
- If you have any further questions, ask your doctor or pharmacist.
- This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their signs of illness are the same as yours.
- If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. See section 4.
What is in this leaflet:
1. What Bicalutamide is and what it is used for
2. What you need to know before you take Bicalutamide
3. How to take Bicalutamide
4. Possible side effects
5. How to store Bicalutamide
6. Contents of the pack and other information
1. What Bicalutamide is and what it is used for
Bicalutamide 50 mg film-coated tablets contains a medicine called bicalutamide. This belongs to a group of medicines called ‘anti-androgens’.
• Bicalutamide is used to treat prostate cancer.
• It works by blocking the effects of male hormones such as testosterone.
2. What you need to know before you take Bicalutamide Do not take Bicalutamide:
• if you are allergic to bicalutamide or any of the other ingredient of this medicine (listed in Section 6).
• if you are already taking a medicine called cisapride or certain anti-histamine medicines (terfenadine or astemizole).
• if you are a woman.
Do not take bicalutamide if any of the above apply to you. If you are not sure, talk to your doctor or pharmacist before taking bicalutamide.
Bicalutamide must not be given to children.
Warnings and precautions
Talk to your doctor or pharmacist before taking bicalutamide:
• if you have any of the following: any heart or blood vessel conditions, including heart rhythm problems (arrhythmia), or are being treated with medicines for these conditions. The risk of heart rhythm problems may be increased when using bicalutamide.
• if you have problems with your liver.
• if you have diabetes and are already taking an ‘LHRH analogue’. These include goserelin, buserelin, leuprorelin and triptorelin.
• if you go into hospital, tell the medical staff that you are taking bicalutamide.
Other medicines and Bicalutamide
Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This includes medicines obtained without a prescription and herbal medicines. This is because bicalutamide can affect the way other medicines work. Also some other medicines can affect the way bicalutamide works.
Do not take bicalutamide if you are already taking any of the following medicines:
• Cisapride (used for some types of indigestion).
• Certain anti-histamine medicines (terfenadine or astemizole).
Bicalutamide might interfere with some medicines used to treat heart rhythm problems (e.g. quinidine, procainamide, amiodarone and sotalol) or might increase the risk of heart rhythm problems when used with some other drugs (e.g. methadone (used for pain relief and part of drug addiction detoxification), moxifloxacin (an antibiotic), antipsychotics used for serious mental illnesses).
Also, tell your doctor or pharmacist if you are taking any of the following medicines:
• Medicines taken by mouth to prevent blood clots (oral anti-coagulants).
• Ciclosporin (to suppress your immune system).
• Calcium channel blockers (to treat high blood pressure or some heart conditions).
• Cimetidine (for stomach problems).
• Ketoconazole (to treat infections caused by a fungus).
Driving and using machines
Bicalutamide is not likely to affect you being able to drive or use any tools or machines. However, if you feel sleepy take care with these activities.
Bicalutamide 50 mg film- coated tablets contains lactose
Bicalutamide 50 mg film-coated tablets contain lactose monohydrate, which is a type of sugar. If you have been told by your doctor that you have intolerance to some sugars, contact your doctor before taking this medicinal product.
3. How to take Bicalutamide
Always take this medicine exactly as your doctor has told you. Check with your doctor or pharmacist if you are not sure.
• The recommended dose for an adult is one tablet each day.
• Swallow the tablet whole with a drink of water.
• Try to take your tablet at the same time each day.
• Do not stop taking this medicine even if you feel well, unless your doctor tells you to.
If you take more Bicalutamide then you should
If you take more bicalutamide than prescribed by your doctor, talk to a doctor or go to a hospital straight away.
If you forget to take Bicalutamide
• If you forget to take a dose, skip the missed dose and take next dose as usual.
• Do not take a double dose (two doses at the same time) to make up for forgotten dose.
If you have any further questions on the use of this medicine, ask your doctor or
pharmacist or nurse.
4. Possible side effects
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Allergic reactions:
These are uncommon (may affect up to 1 in 100 people). The symptoms can include sudden onset of:
• Rash, itching or hives on the skin.
• Swelling of the face, lips, tongue, throat or other parts of the body.
• Shortness of breath, wheezing or trouble breathing.
If this happens to you, see a doctor straight away.
Also tell your doctor straight away if you notice any of the following:
Very common (may affect more than 1 in 10 people):
• Pain in your abdomen.
• Blood in your urine.
Common (may affect up to 1 in 10 people):
• Yellowing of the skin or whites of your eyes (jaundice). These may be signs of liver problems or in rare cases (affects less than 1 in 1,000 people) liver failure.
Uncommon (may affect up to 1 in 100 people):
• Serious shortness of breath or shortness of breath which suddenly gets worse. This may be with a cough or high temperature (fever). These may be signs of an inflammation of the lungs called ‘interstitial lung disease’.
Not known (frequency cannot be estimated from the available data):
• Changes in ECG (QT prolongation).
Other possible side effects:
Very common (may affect more than 1 in 10 people)
• Dizziness.
• Constipation.
• Feeling sick (nausea).
• Swelling and tenderness of your breasts.
• Hot flushes.
• Feeling weak.
• Swelling.
• Low levels of red blood cells (anaemia). This may make you feel tired or look pale.
Common (may affect up to 1 in 10 people)
• Loss of appetite.
• Reduced sex drive.
• Depression.
• Feeling sleepy.
• Indigestion.
• Wind (flatulence).
• Hair loss.
• Hair re-growth or growth of extra hair.
Times New Roman 10 pt Ver.: 02
Last modified: 6 November 2015 4:17 PM
Reason for the Artwork* : Revision of Text/Dimension |
Dimension : 400 x 224 mm | ||||||
Artwork No. : XXXXXXXXXX |
Supersedes No. : XXXXXXXXXX | ||||||
Prepared By PDD |
Checked By PDD |
Approved By | |||||
PDD |
Production |
QA |
I&D RA |
QM |
Country RA | ||
Approved Online |
NA |
• Dry skin.
• Itching.
• Skin rash.
• Being unable to get an erection (impotence).
• Weight gain.
• Chest pain.
• Reduced heart function.
• Heart attack.
Rare (may affect up to 1 in 1,000 people)
• Increased skin sensitivity to sunlight.
Your doctor may do blood tests to check for any changes to your blood.
Do not be concerned by this list of possible side effects. You may not get any of them. Reporting of side effects
If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in this leaflet.
You can also report side effects directly (see details below). By reporting side effects you can help provide more information on the safety of this medicine.
For the UK:
You can report side effects directly via the Yellow card Scheme www.mhra.gov.uk/yellowcard
For Ireland:
You can also report side effects directly via HPRA Pharmacovigilance,
Earlsfort Terrace,
IRL - Dublin 2;
Tel: +353 1 6764971;
Fax: +353 1 6762517.
Website: www.hpra.ie;
E-mail: medsafety@hpra.ie
5. How to store Bicalutamide
Keep this medicine out of the sight and reach of children.
This medicinal product does not require any special storage conditions.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of the month.
Do not use this medicine if you notice any visible signs of deterioration.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
6. Contents of the pack and other information What Bicalutamide 50 mg film-coated tablets contains:
- The active substance is bicalutamide. Each film-coated tablet contains 50 mg of bicalutamide.
Tablet core: The other ingredients are: Lactose monohydrate, sodium starch glycolate Type A, colloidal anhydrous silica, povidone K 30, magnesium stearate.
Film-coating: Opadry white Y-1-7000 which contains hypromellose 5 CP (E464), macrogol 400 and titanium dioxide (E171)).
What Bicalutamide 50 mg film-coated tablets looks like and contents of the pack
Bicalutamide 50 mg film-coated tablets is supplied as white to off white, circular, biconvex film coated tablets. The tablets are packed in blister packs containing 14, 28, 30, 50, 56, 60, 90 and 100 film-coated tablets.
Not all pack sizes may be marketed.
Marketing Authorisation Holder and Manufacturer Fresenius Kabi Oncology Plc
Lion Court
Farnham Road, Bordon Hampshire, GU350NF United Kingdom
Bicalutamide 50 mg film-coated tablets
XXXXXXXXXX XXXXXX XXX
Windows (KP-VINODP) vinodp D:\FK-DATA\Europe\Bicalutamide\MRP\UK\Bicalutamide 50mg-Pack Insert-Bordon-GBR+IRL.indd
Folded: 50 x 28 mm
This medicinal product is authorised in the Member States of the EEA under the following names:
Austria |
Bicalutamid Kabi 50 mg Filmtabletten |
Belgium |
Bicalutamide Fresenius Kabi 50 mg filmomhulde tabletten |
Bulgaria |
Bicalutamide Kabi 50 mg, film-coated tablets |
Denmark |
Bicalutamid Fresenius Kabi |
Estonia |
Bicalutamide Kabi 50 mg |
Greece |
Bicalutamide Kabi, 50 mg/tab, erciKaXnneva ne Xercxo nnevio Stoma |
Spain |
Bicalutamida Kabi 50 mg, comprimidos recubiertos con pehcula EFG |
Hungary |
Bicalutamid Kabi 50 mg filmtabletta |
Ireland |
Bicalutamide 50 mg film-coated tablets |
Lithuania |
Bicalutamide Kabi 50 mg plevele dengtos tabletes |
Netherlands |
Bicalutamide Fresenius Kabi 50 mg filmomhulde tabletten |
Poland |
Bicalutamide Kabi |
Portugal |
Bicalutamida Kabi |
Romania |
Bicalutamida Kabi 50 mg, comprimate filmate |
Slovenia |
Bikalutamid Kabi 50 mg filmsko oblozene tablete |
United Kingdom |
Bicalutamide 50 mg film-coated tablets |
This leaflet was last revised in November 2015
XXX XXXXXX _____ XXXXXXXXXX I
spiqej pa^Boo-uim §ui os opiuitqniBoig
Times New Roman 10 pt Ver.: 02
Last modified: 6 November 2015 4:17 PM
Reason for the Artwork* : Revision of Text/Dimension |
Dimension : 400 x 224 mm | ||||||
Artwork No. : XXXXXXXXXX |
Supersedes No. : XXXXXXXXXX | ||||||
Prepared By PDD |
Checked By PDD |
Approved By | |||||
PDD |
Production |
QA |
I&D RA |
QM |
Country RA | ||
Approved Online |
NA |
Form No.: SOP/PDD/003-03 Rev. 05 CONFIDENTIAL * Attached separate sheet if required